279 related articles for article (PubMed ID: 11170280)
1. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
2. Telomere length dynamics in telomerase-positive immortal human cell populations.
Bryan TM; Englezou A; Dunham MA; Reddel RR
Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
[TBL] [Abstract][Full Text] [Related]
3. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.
Pandita TK; Hall EJ; Hei TK; Piatyszek MA; Wright WE; Piao CQ; Pandita RK; Willey JC; Geard CR; Kastan MB; Shay JW
Oncogene; 1996 Oct; 13(7):1423-30. PubMed ID: 8875980
[TBL] [Abstract][Full Text] [Related]
4. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
5. The shortest telomeres drive karyotype evolution in transformed cells.
der-Sarkissian H; Bacchetti S; Cazes L; Londoño-Vallejo JA
Oncogene; 2004 Feb; 23(6):1221-8. PubMed ID: 14716292
[TBL] [Abstract][Full Text] [Related]
6. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
9. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
10. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
12. Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans.
Britt-Compton B; Rowson J; Locke M; Mackenzie I; Kipling D; Baird DM
Hum Mol Genet; 2006 Mar; 15(5):725-33. PubMed ID: 16421168
[TBL] [Abstract][Full Text] [Related]
13. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines.
Deng W; Tsao SW; Guan XY; Lucas JN; Si HX; Leung CS; Mak P; Wang LD; Cheung AL
Oncogene; 2004 Dec; 23(56):9090-101. PubMed ID: 15489894
[TBL] [Abstract][Full Text] [Related]
14. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
15. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
16. Long-term molecular and cellular stability of human neural stem cell lines.
Villa A; Navarro-Galve B; Bueno C; Franco S; Blasco MA; Martinez-Serrano A
Exp Cell Res; 2004 Apr; 294(2):559-70. PubMed ID: 15023542
[TBL] [Abstract][Full Text] [Related]
17. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
18. Immortalized cells with no detectable telomerase activity. A review.
Reddel RR; Bryan TM; Murnane JP
Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
[TBL] [Abstract][Full Text] [Related]
19. Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter.
Hoare SF; Bryce LA; Wisman GB; Burns S; Going JJ; van der Zee AG; Keith WN
Cancer Res; 2001 Jan; 61(1):27-32. PubMed ID: 11196173
[TBL] [Abstract][Full Text] [Related]
20. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
